MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1055-9965.epi-26-0292

Медицинская библиотека · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026

Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic.

Del Vecchio Natalie J, Doria-Rose V Paul, Todd Kaitlin W, Rendle Katharine A, Chubak Jessica, Halm Ethan A, Alonge Oluwakemi D, Issaka Rachel B, Neslund-Dudas Christine, Honda Stacey, Ziebell Rebecca A, Li Christopher I, Zheng Yingye, Hughes Amy E, Ritzwoller Debra P, Corley Douglas A

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Public health emergencies can substantially affect routine health care. Large cancer screening declines during the early months of the COVID-19 pandemic are well documented; however, COVID-19's impact on follow-up of abnormal screening exams and cancer diagnoses is less reported. We examined the impacts of COVID-19 on the cervical, colorectal, and lung cancer screening processes, within 10 health systems in the Population-based Research to Optimize the Screening Process (PROSPR) consortium.

METHODS

PROSPR data were used to calculate: (i) monthly rates of cancer testing and, for pre-COVID and COVID time periods, (ii) proportions of individuals receiving recommended follow-up within 6 months of an abnormal test, and (iii) cancer incidence. Surveys were used to assess the healthcare systems' local context.

RESULTS

During the first 2 months of the pandemic, cancer testing decreased across all health systems and cancer types (range, 18%-96%). Overall, decreases in monthly rates were followed by rapid recovery to prepandemic rates. The rates of 6-month follow-up of abnormal screening results trended down in the COVID versus pre-COVID periods, as did the diagnosis of new cancers.

CONCLUSIONS

Declines in cancer testing in the early months of the COVID-19 pandemic were short term, with at least short-term impacts on diagnostic follow-up and cancer diagnosis. The systems with the smallest decreases were those that both utilized remote screening outreach (e.g., mailed fecal immunochemical test kits) and did not pause that outreach at the start of the pandemic.

IMPACT: Strategies and policies implemented by healthcare systems during public health emergencies can help minimize disruptions in care. See related In the Spotlight, p. 1481.

Для цитирования: Del Vecchio Natalie J, Doria-Rose V Paul, Todd Kaitlin W, Rendle Katharine A, Chubak Jessica, Halm Ethan A, Alonge Oluwakemi D, Issaka Rachel B, Neslund-Dudas Christine, Honda Stacey, Ziebell Rebecca A, Li Christopher I, Zheng Yingye, Hughes Amy E, Ritzwoller Debra P, Corley Douglas A. Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2026. DOI: 10.1158/1055-9965.epi-26-0292.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.